Heligenics was formed as an LLC in late 2017 and converted to a C corporation in late 2019. The name “Heli” is derived from “hǣlan” an old english word that means “to heal” and “genics” stands for genomics.

Our mission is to prevent disease and heal patients afflicted with illness through genomics.

Our approach is based on the GigaAssay technology developed at the University of Nevada Las Vegas in the Schiller Laboratory of Applied Bioinformatics. The GigaAssay is a massively parallel biological assay that can simultaneously measure how millions of genetic variants or other sequence variables affect a molecular function of cell process. To date, there are no other established assays that assess biological function.

The GigaAssay produces functional genomics data that can be licensed and used for prevention-based approaches, diagnostics. Additionally, for developing new drug therapies or redesigning clinical trials for drugs that have failed a trial due to poor efficacy or safety. Heligenics products will transform the medical industry.

To access a one-page description of Heligenics, press the button below.